Humanized MISTRG as a preclinical in vivo model to study human neutrophil-mediated immune processes

MISTRG mice have been genetically modified to allow development of a human myeloid compartment from engrafted human CD34+ haemopoietic stem cells, making them particularly suited to study the human innate immune system . Here, we characterized the human neutrophil population in these mice to establi...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 14; p. 1105103
Main Authors Martinez-Sanz, Paula, Laurent, Adrien R G, Slot, Edith, Hoogenboezem, Mark, Bąbała, Nikolina, van Bruggen, Robin, Rongvaux, Anthony, Flavell, Richard A, Tytgat, Godelieve A M, Franke, Katka, Matlung, Hanke L, Kuijpers, Taco W, Amsen, Derk, Karrich, Julien J
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 08.03.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:MISTRG mice have been genetically modified to allow development of a human myeloid compartment from engrafted human CD34+ haemopoietic stem cells, making them particularly suited to study the human innate immune system . Here, we characterized the human neutrophil population in these mice to establish a model that can be used to study the biology and contribution in immune processes of these cells . We could isolate human bone marrow neutrophils from humanized MISTRG mice and confirmed that all neutrophil maturation stages from promyelocytes (CD11b-CD16-) to end-stage segmented cells (CD11b+CD16+) were present. We documented that these cells possessed normal functional properties, including degranulation, reactive oxygen species production, adhesion, and antibody-dependent cellular cytotoxicity towards antibody-opsonized tumor cells . The acquisition of functional capacities positively correlated with the maturation state of the cell. We found that human neutrophils were retained in the bone marrow of humanized MISTRG mice during steady state. However, the mature segmented CD11b+CD16+ human neutrophils were released from the bone marrow in response to two well-established neutrophil-mobilizing agents (i.e., G-CSF and/or CXCR4 antagonist Plerixafor). Moreover, the neutrophil population in the humanized MISTRG mice actively reacted to thioglycolate-induced peritonitis and could infiltrate implanted human tumors, as shown by flow cytometry and fluorescent microscopy. These results show that functional human neutrophils are generated and can be studied using the humanized MISTRG mice, providing a model to study the various functions of neutrophils in inflammation and in tumors.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors share last authorship
Edited by: Nabiha Yusuf, University of Alabama at Birmingham, United States
Reviewed by: Hitoshi Takizawa, Kumamoto University, Japan; Ali Roghanian, University of Southampton, United Kingdom; Julien Faget, INSERM U1194 Institut de Recherche en Cancérologie de Montpellier (IRCM), France
This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2023.1105103